Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David C. Ott currently holds 4,890,595 shares of Zentalis Pharmaceuticals, Inc. (ZNTL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David C. Ott has been a net seller of ZNTL stock. They have purchased $226.8M and sold $525.2M worth of shares.
David C. Ott's most recent insider trade was on Jun 17, 2024, when they sold 39,032 shares at $38.15 per share.
David C. Ott serves as Executive at Zentalis Pharmaceuticals, Inc. (ZNTL). They have executed 46 insider transactions totaling $752.0M over their tenure at the company.
David C. Ott holds the position of Executive at Zentalis Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
David C. Ott has shown a selling trading pattern, with $226.8M in total purchases and $525.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David C. Ott was on Feb 28, 2024, when they sold $197.7M worth of APG shares. This transaction involved 8,036,862 shares at $24.60 per share.
David C. Ott currently owns 4,890,595 shares of Zentalis Pharmaceuticals, Inc. (ZNTL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David C. Ott's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David C. Ott has 46 Form 4 filings on record as an insider at Zentalis Pharmaceuticals, Inc..
Set alerts for David C. Ott and 40,000+ other insiders.